2 nominees · 5 ballot items.
Re-elect two directors; ratify Audit Alliance LLP as independent auditors; approve the 2026 Stock Incentive Plan; approve a board-authorized reverse stock split (1-for-5, 1-for-10, or 1-for-14) with fractional shares rounded up; and approve an increase in authorized common shares from 50,000,000 to 50,000,000,000.
Vote to re-elect Jinhao Pang and Xu Zhao as Class I directors to serve until the 2028 annual meeting.
Ratify the Audit Committee’s selection of Audit Alliance LLP as the Company's independent registered public accounting firm for the fiscal year ending June 30, 2026.
Approve the Singularity Future Technology Ltd. 2026 Stock Incentive Plan, authorizing equity awards (options and stock grants) to employees, directors and consultants with a share reserve up to 15% of issued and outstanding shares.
This management proposal asks shareholders to approve the 2026 Stock Incentive Plan, a broad equity compensation program administered by the Compensation Committee that authorizes incentive stock options, nonqualified options and shares to employees, non-employee directors and consultants. Management seeks shareholder approval because the plan creates the legal authorization to issue equity-based awards and reserves shares (up to 15% of issued and outstanding common stock) that would otherwise require shareholder consent; the Board views these awards as tools to attract, retain, and motivate personnel critical to long-term growth. The Plan grants the Compensation Committee substantial discretion over award terms, vesting, transfer restrictions and change-of-control treatments, which provides flexibility but concentrates governance authority in the Committee. From a governance and investor-impact perspective, the principal trade-off is potential dilution from the reserve and the Committee’s broad authority versus the expected benefit of aligning executives’ incentives with shareholder value creation. The Plan contains standard tax and administrative provisions, a ten-year term, and explicit mechanisms for amendment and termination, with Board-level limits on amendments that would require shareholder approval. The Company discloses customary tax consequences for option grants and stock awards, signaling that awards will follow conventional tax treatments and that recipients could face ordinary income recognition on vesting or exercise depending on award type and elections. The Board’s recommendation emphasizes the strategic rationale — incentivizing contributors to enhance firm value — while noting that precise award recipients and amounts are not determinable at present. A sophisticated evaluator should weigh the size of the proposed share reserve (15% of outstanding) relative to the company’s small base of outstanding shares and consider dilution, potential impact on EPS and voting power, and the governance controls (committee composition, transferability limits, and amendment provisions) that will shape how awards are used. Overall, the proposal is typical for a growth-stage company seeking flexibility to grant equity compensation, but investors should monitor future award schedules, vesting and repricing practices for dilution and alignment implications.
Authorize the Board to amend the Articles to effect a reverse stock split at a 1-for-5, 1-for-10, or 1-for-14 ratio with fractional shares rounded up, with the Board retaining discretion over the exact ratio and timing within one year of approval.
This management proposal requests shareholder approval to amend the Articles of Incorporation to permit a board-authorized reverse stock split at a ratio of 1-for-5, 1-for-10, or 1-for-14, with fractional shares rounded up, and grants the Board discretion over the exact ratio and timing within one year of approval. Management seeks this authority primarily as a potential remedy for the Company’s non-compliance with Nasdaq’s $1.00 minimum bid price requirement, and the Board can implement the split only if it subsequently determines the action is in the Company’s best interests. The proposal gives the Board flexibility to select among multiple split ratios to maximize potential benefits such as meeting listing requirements, improving perceived marketability, and appealing to institutional investors that avoid low-priced stocks. The filing discloses the Nasdaq deficiency history and explains that the split, if implemented, may help regain compliance by increasing the per-share price, but it also candidly notes there is no guarantee of sustained price improvement. Important investor risks are highlighted: potential decreased liquidity, larger percentage declines in market capitalization post-split if the stock falls, increased odd-lot holdings and higher transaction costs for some shareholders, and potential anti-takeover implications due to a larger authorized-but-unissued share pool. The proposal also provides for rounding up fractional shares, which benefits small holders but marginally increases dilution. From a governance standpoint, the Board retains unilateral discretion after approval to abandon or delay the split if conditions change, concentrating practical control with management. A sophisticated analyst should weigh the urgency of Nasdaq compliance, the likelihood that the selected ratio will achieve the $1.00 threshold given trading dynamics, dilution and liquidity trade-offs, and the Board’s willingness to exercise its post-approval discretion responsibly.
Amend the Articles of Incorporation to increase authorized common shares from 50,000,000 to 50,000,000,000 to provide flexibility for future financings, acquisitions, employee plans and other corporate purposes.
This proposal asks shareholders to approve a large increase in the number of authorized common shares from 50 million to 50 billion, effectively adding 49.95 billion shares to the corporate charter for future issuance. Management frames the amendment as a pragmatic measure to provide flexibility to issue equity for financings, acquisitions, employee plans and general corporate purposes without the delay and cost of convening a special shareholder meeting. The primary investor concern is dilution: the newly authorized shares, if issued, could substantially dilute existing shareholders’ percentage ownership, voting power, and earnings per share—especially because shareholders have no preemptive rights. From a governance perspective, the amendment grants the Board broad discretion over future issuances, which could be used to act quickly but also raises the risk of opportunistic or value-dilutive issuances if not constrained by shareholder oversight or protective charter provisions. The company asserts no immediate issuance plan, and the amendment will not change other shareholder rights or preferred stock authorizations, but investors should scrutinize any subsequent issuance proposals for pricing, strategic rationale and timing. For a sophisticated analyst, the key questions are whether the company truly needs this headroom given its current capital structure and capital-raising prospects, what guardrails (e.g., shareholder approvals for certain transactions) exist, and how management intends to use the additional capacity to create value rather than simply dilute. The Board recommends a vote FOR, citing ability to respond promptly to opportunities; however, shareholders should demand transparency and appropriate governance safeguards on any future large issuances.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | 1.8% | 131,237 | $55K |
| 2 | CITIGROUP INC | 0.7% | 54,172 | $23K |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 0.6% | 40,146 | $17K |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 0.5% | 36,275 | $15K |
| 5 | XTX Topco Ltd | 0.3% | 25,183 | $10K |
| 6 | TWO SIGMA SECURITIES, LLC | 0.3% | 21,524 | $9K |
| 7 | Nordwand Advisors, LLC | 0.2% | 15,000 | $6K |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 0.1% | 4,119 | $2K |
| 9 | Tower Research Capital LLC (TRC | 0.0% | 3,350 | $1K |
| 10 | UBS Group AG | 0.0% | 517 | $215 |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.